Use access key #2 to skip to page content.

Recs

6

Apple Is Up 37% Year-Over-Year. What Now?

April 28, 2014 – Comments (0) | RELATED TICKERS: AAPL

I ran across this interesting assessment regarding AAPL and wanted to share the post here. 

Apple Is Up 37% Year-Over-Year. What Now?  [more]

Recs

5

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells

March 02, 2014 – Comments (0) | RELATED TICKERS: ISCO

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.  [more]

Recs

6

GALT

February 26, 2014 – Comments (1) | RELATED TICKERS: GALT

Finally, clinical-stage drug developer Galectin Therapeutics (NASDAQ: GALT  ) jumped 15% after announcing a preclinical study that supports its investigational new drug application for GR-MD-02 in nonalcoholic steatohepatitis, or NASH. Specifically, hyaluronic acid, a biomarker of liver fibrosis, which is common with NASH, was reduced by 33% in animals treated with GR-MD-02 compared to untreated animals. As we've witnessed withIntercept Pharmaceuticals' recent $200-per-share move following its midstage results on obeticholic acid, there's a huge market for treating advanced NASH cases (approximately 6 million people), so these early results could be encouraging. Keep in mind, though, that how a drug responds in animal testing can be completely different from how it responds in human clinical trials. Don't get too excited just yet.  [more]

Recs

9

Occam's Razor

June 02, 2013 – Comments (3)

" 8 Top Stock Blogs

By Matt Koppenheffer | More Articles | Save For Later 
January 3, 2008 | Comments (0)
  [more]

Featured Broker Partners


Advertisement